33.81
price up icon0.36%   0.12
after-market Handel nachbörslich: 33.50 -0.31 -0.92%
loading

Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten

pulisher
11:23 AM

TG Therapeutics (TGTX) Margin Miss Challenges Growth-Driven Profitability Narrative - Yahoo Finance

11:23 AM
pulisher
11:19 AM

TG Therapeutics (NASDAQ:TGTX) Given New $49.00 Price Target at JPMorgan Chase & Co. - MarketBeat

11:19 AM
pulisher
10:26 AM

TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised - TradingView

10:26 AM
pulisher
10:13 AM

TG Therapeutics (TGTX): Exploring Valuation as Growth Prospects Spark Investor Interest - Yahoo Finance

10:13 AM
pulisher
09:27 AM

TG Therapeutics (NASDAQ:TGTX) Announces Quarterly Earnings Results, Beats Estimates By $2.19 EPS - MarketBeat

09:27 AM
pulisher
09:08 AM

Tools to assess TG Therapeutics Inc.’s risk profileMarket Activity Report & Safe Investment Capital Preservation Plans - newser.com

09:08 AM
pulisher
08:24 AM

TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript - Insider Monkey

08:24 AM
pulisher
06:30 AM

Hussman Strategic Advisors Inc. Grows Position in TG Therapeutics, Inc. $TGTX - MarketBeat

06:30 AM
pulisher
06:16 AM

TG Therapeutics: Q3 Earnings Snapshot - theheraldreview.com

06:16 AM
pulisher
06:05 AM

HC Wainwright Predicts Reduced Earnings for TG Therapeutics - MarketBeat

06:05 AM
pulisher
04:37 AM

Will TG Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com

04:37 AM
pulisher
01:43 AM

How TG Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com

01:43 AM
pulisher
01:20 AM

Building trade automation scripts for TG Therapeutics Inc.July 2025 Sentiment & Verified Momentum Watchlists - newser.com

01:20 AM
pulisher
Nov 03, 2025

How to build a dashboard for TG Therapeutics Inc. stockJuly 2025 Movers & Weekly High Return Opportunities - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics raises BRIUMVI 2025 revenue guidance to $585M while advancing subcutaneous pipeline - MSN

Nov 03, 2025
pulisher
Nov 03, 2025

Is now a turning point for TG Therapeutics Inc.Short Setup & Daily Risk Controlled Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Inc (TGTX) Q3 2025 Earnings Call Highlights: Rec - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Inc (TGTX) Q3 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ... - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Q3 Earnings: Strong Quarter For Briumvi As CD20 Market Grows (NASDAQ:TGTX) - Seeking Alpha

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics, Inc. Raises Earnings Guidance for the Year 2025 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics (TGTX) Reports Strong Q3 2025 Results Driven by BRIUMVI - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Transcript : TG Therapeutics, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

TGTX: JP Morgan Raises Price Target to $49, Maintains Overweight Rating | TGTX Stock News - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Earnings call transcript: TG Therapeutics Q3 2025 beats EPS forecast, stock dips - Investing.com Canada

Nov 03, 2025
pulisher
Nov 03, 2025

Earnings call transcript: TG Therapeutics Q3 2025 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug - Stocktwits

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics (TGTX) Reports Strong Q3, Raises 2025 Revenue Gu - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Inc (TGTX) Reports Q3 2025 Revenue of $161.7 Mil - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics (TGTX) Increases 2025 BRIUMVI Revenue Forecast - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics (TGTX) Surpasses Q3 Revenue Expectations and Exp - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Q3 Earnings: $390.9M Net Income, Beats ForecastsNews and Statistics - IndexBox

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Q3 Net Income, Revenue Rise; Raises 2025 Revenue Guidance - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Earnings Flash (TGTX) TG Therapeutics, Inc. Reports Q3 Revenue $161.7M, vs. FactSet Est of $152.1M - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Analyzing recovery setups for TG Therapeutics Inc. investorsJuly 2025 Price Swings & Short-Term Swing Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What dividend safety score for TG Therapeutics Inc. stockTrade Performance Summary & Risk Controlled Swing Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

TG Therapeutics Builds On BRIUMVI's Momentum Ahead Of Q3 Earnings And 2027 Launch Plans - RTTNews

Nov 03, 2025
pulisher
Nov 03, 2025

Can TG Therapeutics Inc. stock resist market sell offsWall Street Watch & Long-Term Capital Growth Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is it time to cut losses on TG Therapeutics Inc.Dividend Hike & Daily Chart Pattern Signal Reports - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is TG Therapeutics Inc. stock oversold or undervaluedJuly 2025 Earnings & Precise Buy Zone Identification - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How TG Therapeutics Inc. (NKB2) stock trades under stagflationQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How to escape a deep drawdown in TG Therapeutics Inc.Breakout Watch & Daily Chart Pattern Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is TG Therapeutics Inc. stock a good choice for value investorsJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will TG Therapeutics Inc. stock outperform value stocksJuly 2025 Reactions & Short-Term High Return Strategies - newser.com

Nov 02, 2025
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):